Twist Bioscience Corporation TWST Reportable Segment — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's reportable segment — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Twist Bioscience Corporation's reportable segment — revenue?
- Twist Bioscience Corporation (TWST) reported reportable segment — revenue of $110.72M in Q1 2026.
- How has Twist Bioscience Corporation's reportable segment — revenue changed year-over-year?
- Twist Bioscience Corporation's reportable segment — revenue increased by 19.3% year-over-year, from $92.79M to $110.72M.
- What does reportable segment — revenue mean?
- Represents the total gross inflow of economic benefits arising from the ordinary operating activities of the reportable business segment. It reflects the market demand for the segment's products or services and serves as the primary indicator of top-line growth and market penetration.